James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Why Nvidia Corporation (NVDA), Express, Inc. (EXPR) and Dollar General Corp. (DG) Are 3 of Today’s Worst Stocks

Nvidia (NVDA), Express (EXPR) and Dollar General (DG) never even had a shot at bullishness on Thursday. Here's what you need to know.

The 10 Best Healthcare Stocks to Buy for 2017

These are the 10 best healthcare stocks to buy going forward after the 2016 presidential election shook up the whole sector.

Starbucks Corporation (SBUX) Stock Is Still Stuck in the Past

Starbucks defined the marriage of coffee houses and large chains. But that pairing isn't quite as marketable for SBUX stock as it used to be.

Why Valeant Pharmaceuticals Intl Inc (VRX), Barrick Gold Corporation (USA) (ABX) and Autodesk, Inc. (ADSK) Are 3 of Today’s Worst Stocks

Valeant Pharmaceuticals (VRX), Barrick Gold (ABX) and Autodesk (ADSK) never even had a shot at making forward progress on Wednesday.

Should Apple Inc. (AAPL) Stock Holders FEAR the iPhone 8?

Apple (AAPL) will launch the much-anticipated iPhone 8 next year. But believe it or not, that could make it MORE difficult to own AAPL stock.